Envoy Medical (COCH) Preferred Stock Liabilities (2021 - 2026)

Envoy Medical's Preferred Stock Liabilities history runs 5 years deep, the most recent figure standing at $391000.0 for Q1 2026.

• In Q1 2026, Preferred Stock Liabilities changed N/A year-over-year to $391000.0; the TTM figure through Mar 2026 stood at $391000.0 (changed N/A YoY), while the FY2025 annual figure was $391000.0, changed N/A from the prior year.
• Preferred Stock Liabilities came in at $391000.0 for Q1 2026 at Envoy Medical, roughly flat from $391000.0 in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $429.7 million in Q4 2022 to a low of $130000.0 in Q3 2025.
• A 4-year average of $199.6 million and a median of $44.6 million in 2023 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities climbed 1.19% in 2022 and plunged 89.61% in 2023, its largest moves.
• Envoy Medical's Preferred Stock Liabilities stood at $429.7 million in 2022, then tumbled by 89.62% to $44.6 million in 2023, then plunged by 99.12% to $391000.0 in 2025, then changed by 0.0% to $391000.0 in 2026.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $391000.0, $391000.0, and $130000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison